4 companies on verge of settling US opioid lawsuits


              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photos shows an AmerisourceBergen Corp. office building in Conshohocken, Pa.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Matt Rourke, File)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              Nassau County Executive Laura Curran, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Suffolk County Executive Steve Bellone is behind her. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              Suffolk County Executive Steve Bellone, right, speaks at a news conference to discuss a settlement in an opioid trial, Tuesday, July 20, 2021, in Central Islip, N.Y. Nassau County Executive Laura Curran is behind him. New York State reached an agreement Tuesday with the distribution companies AmerisourceBergen, Cardinal Health and McKesson to settle an ongoing trial. That deal alone would generate more than $1 billion to abate the damage done by opioids there. The trial is expected to continue, but the settlement leaves only three drug manufacturers as defendants. (AP Photo/Mark Lennihan)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Darron Cummings, File)
            
              FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco. A $26 billion settlement between the three biggest U.S. drug distribution companies and drugmaker Johnson & Johnson and thousands of states and municipalities that sued over the toll of the opioid crisis is certainly significant, but it is far from tying a neat bow on the tangle of still unresolved lawsuits surrounding the epidemic. (AP Photo/Jeff Chiu, File)
            
              FILE - This Oct. 16, 2019, file photo shows a sign of the Cardinal Health, Inc. corporate office in Dublin, Ohio.  The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of lawsuits over the toll of opioids across the U.S., two people with knowledge of the plans told The Associated Press. The settlement involving Cardinal Health, AmerisourceBergen and McKesson is expected this week. A $1 billion-plus deal involving the three distributors and the state of New York was planned for Tuesday, July 20, 2021.  (AP Photo/Darron Cummings, File)
            FILE - In this July 17, 2019, file photo, a pedestrian passes a McKesson sign on an office building in San Francisco.  The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of lawsuits over the toll of opioids across the U.S., two people with knowledge of the plans told The Associated Press. The settlement involving McKesson, AmerisourceBergen and Cardinal Health is expected this week. A $1 billion-plus deal involving the three distributors and the state of New York was planned for Tuesday, July 20, 2021.   (AP Photo/Jeff Chiu, File) FILE - This Aug. 29, 2018, file photo shows an arrangement of Oxycodone pills in New York.  The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of lawsuits over the toll of opioids across the U.S., two people with knowledge of the plans told The Associated Press. The settlement involving AmerisourceBergen, Cardinal Health and McKesson is expected this week. A $1 billion-plus deal involving the three distributors and the state of New York was planned for Tuesday, July 20, 2021. (AP Photo/Mark Lennihan, File) FILE - In this Feb. 24, 2021, file photo, Johnson & Johnson logo appears on the exterior of a first aid kit in Walpole, Mass. The three biggest U.S. drug distribution companies and the drugmaker Johnson & Johnson are on the verge of a $26 billion settlement covering thousands of lawsuits over the toll of opioids across the U.S., two people with knowledge of the plans told The Associated Press. The settlement involving AmerisourceBergen, Cardinal Health and McKesson is expected this week. A $1 billion-plus deal involving the three distributors and the state of New York was planned for Tuesday, July 20.   (AP Photo/Steven Senne, File)